Aimei Health Technology (NASDAQ:AFJK) Reaches New 12-Month High – What’s Next?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $98.15 and last traded at $88.50, with a volume of 6428936 shares trading hands. The stock had previously closed at $8.00.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Monday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Aimei Health Technology Stock Performance

The company has a market capitalization of $541.62 million, a P/E ratio of 421.45 and a beta of 0.03. The firm has a 50 day moving average price of $11.26 and a two-hundred day moving average price of $11.22.

Aimei Health Technology (NASDAQ:AFJK) last announced its earnings results on Tuesday, November 18th. The company reported $0.06 earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP grew its position in Aimei Health Technology by 4.7% during the 1st quarter. Quarry LP now owns 157,081 shares of the company’s stock worth $1,729,000 after acquiring an additional 7,081 shares during the last quarter. Polar Asset Management Partners Inc. bought a new position in Aimei Health Technology in the 1st quarter valued at $110,000. Wellspring Financial Advisors LLC acquired a new position in Aimei Health Technology in the second quarter worth $133,000. Clear Street LLC grew its holdings in shares of Aimei Health Technology by 63.8% during the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after purchasing an additional 15,399 shares during the last quarter. Finally, Berkley W R Corp grew its holdings in shares of Aimei Health Technology by 5.9% during the third quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock worth $5,101,000 after purchasing an additional 25,294 shares during the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.